Confirming the utility of four kidney biomarker tests in a longitudinal follow-up study

Renal Failure

Volumn 25, Issue 5, 2003, Pages 797-817

  Sarasua, Sara M ^a   Mueller, Patricia ^b   Kathman, Steven ^a   Campagna, Dave ^a   Uddin, Mohammed S ^a   White, Mary C ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Alanine aminopeptidase; Albumin; Biomarkers; Creatinine; Creatinine clearance; Cystatin C; Kidney disease; N acetyl D glucosaminidase; Retinol binding protein

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; MICROSOMAL AMINOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE; RETINOL BINDING PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FOLLOW UP; GOUT; HEART DISEASE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URINARY TRACT DISEASE; URINE OSMOLALITY;

ACETYLGLUCOSAMINIDASE; ADOLESCENT; ADULT; AGED; ALBUMINURIA; ANTIGENS, CD13; BIOLOGICAL MARKERS; CHILD; CREATININE; CYSTATINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETINOL-BINDING PROTEINS;

EID: 0141507010     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120024295     Document Type: Article

References (44)

1. Agency for Toxic Substances and Disease Registry. Biomarkers of Kidney Function for Environmental Health Field Studies. Atlanta: U.S. Department of Health and Human Services, Public Health Service, 1998a.
2. Mueller, P.W.; Price, R.B.; Finn, W.F. New approaches for detecting thresholds of human nephrotoxicity using cadmium as an example. Environ. Health Perspect. 1998, 106 (5), 227-230.
3. Wedeen, R.P.; Udasin, I.; Fiedler, N.; D'Haese, P.; De Broe, M.; Gelpi, E.; Jones, K.W.; Gochfeld, M. Urinary biomarkers as indicators of renal disease. Ren. Fail. 1999, 21, 241-249.
4. Mueller, P.W.; Lash, L.H.; Price, R.G.; Stolte, H.; Gelpi, E.; Maack, T. ; Berndt, W.O. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. I: categories of tests for detecting effects of nephrotoxins. Ren. Fail. 1997a, 19 (4), 505-521.
5. Mueller, P.W.; Price, R.G.; Porter, G.A. Proceedings of the Joint US/EU Workshop: Urinary Biomarkers to Detect Significant Effects of Environmental and Occupational Exposure to Nephrotoxins. Ren. Fail. 1997b, 19 (4), 501-504.
6. Bakris, G.L. Microalbuminuria: what is it? why is it important? what should be done about it? J. Clin. Hyperten. 2001, 3, 99-102.
7. Kordonouri, O.; Kahl, A.; Jorres, A.; Hopfenmuller, W.; Muller, C.; Danne, T. The prevalence of incipient tubular dysfunction, but not of glomerular dysfunction, is increased in patients with diabetes onset in childhood. J. Diab. Comp. 1999, 13, 320-324.
8. Moore, T.H.; Shield, J.P. Prevalence of abnormal urinary albumin excretion in adolescents and children with insulin dependent diabetes: the MIDAC study. Microalbinuria in Diabetic Adolescents and Children (MIDAC) research group. Arch. Dis. Child. 2000, 83 (3), 239-243.
9. Royal College of Physicians. Near-normal urinary albumin concentrations predict progression to diabetic nephropathy in type 1 diabetes mellitus. Diabet. Med. 2000, 17, 782-791.
10. Twyman, S.; Rowe, D.; Mansell, P.; Schapira, D.; Betts, P.; Leatherdale, B. Longitudinal study of urinary excretion in young diabetic patients - Wessex Diabetic Nephropathy Project. Diabet. Med. 2001, 18, 402-408.
11. Nishijo, M.; Nakagawa, H.; Morikawa, Y.; Miura, K.; Tabata, M.; Ishizaki, M. Microalbuminuria and hypertension in nondiabetic Japanese men. Am. J. Hypertens. 1999, 12, 16-20.
12. Jager, A.; Kostense, P.J.; Ruhe, H.G.; Heine, R.J.; Nijpels, G.; Dekker, J.M.; Bouter, L.M.; Stehouwer, C.D.A. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 617-624.
13. Groop, L.; Ekstrand, A.; Forsblom, C.; Widen, E.; Groop, P.H.; Teppo, A.M.; Eriksson, J. Insulin resistance, hypertension, and microalbuminuria in patients with type 2 (noninsulin-dependent) diabetes mellitus. Diabetologia 1993, 36 (7), 642-647.
14. Martinez, M.A.; Moreno, A.; Aguirre de Carcer, A.; Cabrera, R.; Rocha, R.; Torre, A.; Nevado, A.; Ramos, T.; Neri, J.; Anton, G.; Miranda, I.; Fernandez, P.; Rodrigues, E.; Miguel, A.; Martinez, J.L.; Rodriguez, M.; Eisman, C.; Puig, J.G. Frequency and determinants of microalbuminuria in mild hypertension: a primary care based study. J. Hypertens. 2001, 19, 319-326.
15. Tomura, S.; Kawada, K.; Saito, K.; Lin, Y.L.; Endou, K.; Hirano, C.; Yanagi, H.; Tsuchiya, S.; Shiba, K. Prevalence of microalbuminuria and relationship to the risk of cardiovascular disease in the Japanese population. Am. J. Nephrol. 1999, 19, 13-20.
16. Hillege, H.L.; Janssen, W.M.T.; Bak, A.A.A.; Kiercks, G.F.H.; Grobbee, D.E.; Crijns, H.J.G.M.; Van Gilst, W.H.; De Zeeuw, D.; De Jong, P.E. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J. Int. Med. 2001, 249, 519-526.
17. Rachmani, R.; Levi, Z.; Lida, M.; Slavachevski, I.; Half-Onn, E.; Ravid, M. Considerations about the threshold value of microalbuminuria in patients with diabetes mellitus: lessons from an 8-year follow-up study of 599 patients. Diabetes Res. Clin. Pract. 2000, 49, 187-194.
18. Roest, M.; Banga, J.D.; Janssen, W.M.T.; Grobbee, D.E.; Sixma, J.J.; de Jong, P.E.; de Zeeuw, D.; van der Schouw, Y.T. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 2001, 103, 3057-3061.
19. Mueller, P.W.; Paschal, D.C.; Hammel, R.R.; Klincewicz, S.L.; MacNeil, M.L.; Spierto, B.; Steinberg, K.K. Chronic renal effects in three studies of men and women occupationally exposed to cadmium. Arch. Environ. Contam. Toxicol. 1992, 23, 125-136.
20. Ellingsen, D.G.; Efskind, J.; Berg, K.J.; Gaarder, P.I.; Thomassen, Y. Renal and immunologic markers for chloralkali workers with low exposure to mercury vapor. Scand. J. Work Environ. Health 2000, 26, 427-435.
21. Lauwerys, R.; Bernard, A.; Cardenas, A. Monitoring of early nephrotoxic effects of industrial chemicals. Toxicol. Lett. 1992, 64/65, 33-42.
22. Cardenas, A.; Roels, H.; Bernard, A.M.; Barbon, R.; Buchet, J.P.; Lauwerys, R.R.; Rosello, J.; Ramis, I.; Mutti, A.; Franchini, I.; Fels, I.M.; Stolte, H.; De Broe, M.E.; Nuyts, G.D.; Taylor, S.A.; Price, R.G. Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead. Brit. J. Ind. Med. 1993, 50, 28-36.
23. Mutti, A.; Alinovi, R.; Bergamaschi, E.; Biagini, C.; Cavazzini, S.; Franchini, I.; Lauwerys, R.R.; Bernard, A.M.; Roels, H.; Gelpi, E. Nephropathies and exposure to perchlorethylene in dry cleaners. Lancet 1992, 340, 189-193.
24. Roels, H.A.; Hoet, P.; Lison, D. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity. Ren. Fail. 1999, 21, 251-262.
25. Lim, Y.C.; Chia, K.S.; Ong, H.Y.; Ng, V.; Chew, Y.L. Renal dysfunction in workers exposed to inorganic lead. Ann. Acad. Med. Singapore 2001 Mar, 30 (2), 112-7.
26. Drake, P.L.; Rojas, M.; Reh, C.M.; Mueller, C.A.; Jenkins, F.M. Occupational exposure to airborne mercury during gold mining operations near El callao, Venezuela. Int. Arch. Occup. Environ. Health 2001, 74, 206-212.
27. Suwazono, Y.; Kobayashi, E.; Okubo, Y.; Nogawa, K.; Kido, T.; Nakagawa, H. Renal effects of cadmium exposure in cadmium nonpolluted areas in Japan. Environ. Res. 2000, 84, 44-55.
28. Noonan, C.W.; Sarasua, S.M.; Campagna, D.; Kathman, S.J.; Lybarger, J.A. ; Mueller, P.W. Effects of exposure to low levels of environmental cadmium on renal biomarkers. Environ. Health Perspect. 2002, 110 (2), 151-155.
29. Kurttio, P.; Auvinen. A.; Salonen, L.; Saha, H.; Pekkanen, J.; Mäkeläinen, I.; Väisänen, S.B.; Penttilä, I.M.; Komulainen, H. Environ. Health Perspect. 2002, 110, 337-342.
30. Mueller, P.W.; Hall, W.D.; Caudill, S.P.; MacNeil, M.L.; Arepally, A. An in-depth examination of the excretion of albumin and other sensitive markers of renal damage in mild hypertension. Am. J. Hypertens. 1995, 8 (11), 1072-1082.
31. Mueller, P.W.; Caudill, S.P. Urinary albumin excretion in children: factors related to elevated excretion in the United States population. Ren. Fail. 1999, 21, 293-302.
32. Amler, R.W.; Mueller, P.W.; Schultz, M.G., Eds. Biomakers of Kidney Function for Environmental Health Field Studies. Agency for Toxic Substances and Disease Registry. U.S. Department of Health and Human Services. Public Health Service. April 1998.
33. Lybarger, J.A.; Lichtveld, M.Y.; Amler, R.W. Biomedical testing of the kidney for persons exposed to hazardous substances in the environment. Ren. Fail. 1999, 21 (3 and 4), 263-274.
34. Agency for Toxic Substances and Disease Registry. McClellan Air Force Base Cross-Sectional Health Study, Sacramento, Sacramento County, California. Atlanta: U.S. Department of Health and Human Services, Public Health Service, 1996a.
35. Agency for Toxic Substances and Disease Registry. Health Study of Communities Surrounding Otis Air National Guard Base/Camp Edwards, Falmouth, Massachusetts. Atlanta: U.S. Department of Health and Human Services, Public Health Service, 1998b.
36. Agency for Toxic Substances and Disease Registry. Symptom and Disease Prevalence with Biomarkers Health Study, Cornhusker Army Ammunition Plant, Hall County, Nebraska. Atlanta: U.S. Department of Health and Human Services, Public Health Service, 1996b.
37. Agency for Toxic Substances and Disease Registry. A Longitudinal Study of the Reversibility and Value of Selected Kidney Biomarkers. Atlanta: U.S. Department of Health and Human Services, Public Health Service, 2001.
38. Mueller, P.W.; MacNeil, M.L.; Steinberg, K.K. Biological reference materials for assaying human albumin in urine. Fresenius J. Anal. Chem. 1990, 338, 543-546.
39. Mueller, P.W.; MacNeil, M.L.; Steinberg, K.K. Stabilization of alanine aminopeptidase, gamma glutamyltranspeptidase, and N-acetyl-β -D-glucosaminidase activity in normal urines. Arch. Environ. Contam. Toxicol. 1986, 15, 343-347.
40. Topping, M.D.; Forster, H.W.; Dolman, C.; Luczynska, C.M.; Bernard, A.M. Measurement of urinary retinol-binding protein by enzyme linked immunosorbent assay and its application to detection of tubular proteinuria. Clin. Chem. 1986, 32,1863-1866.
41. Tietz, N.W., Ed. Clinical Guide to Laboratory Tests. Philadelphia: WB Saunders Company, 1995.
42. Price, R.G.; Patel, S.; Chivers, I.; Milligan, P.; Taylor, S.A. Early markers of nephrotoxicity: detection of children at risk from environmental pollution. Ren. Fail. 1999, 21, 303-308.
43. Bernard, A.; Stolte, H.; DeBroe, M.E.; Mueller, P.W.; Mason, H.; Lash, L.H.; Fowler, B.A. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxics. IV: current information on interpreting the health implications of tests. Ren. Fail. 1997, 19, 553-566.
44. DeGroot, M.H. Probability and Statistics. Menlo Park, CA: Addison-Wesley. 1989.